An appraisal of T cell subsets and the potential for autoimmune injury

Kidney International

Volumn 53, Issue 6, 1998, Pages 1574-1584

  Kelly, Carolyn J ^a   Frishberg, Yaacov ^b   Gold, Daniel P ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

Antigen presenting cells; Cytokines; Glycoproteins; Immune response; Inflammation; Receptor ligand; Signal transduction; Th1 Th2; Transcription factors

Indexed keywords

TRANSCRIPTION FACTOR;

ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; CONFERENCE PAPER; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; LIGAND BINDING; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION;

EID: 0031779320     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00917.x     Document Type: Conference Paper

References (119)

1. MOSMANN TR, CHERWINSKI H, BOND MW, GIEDLIN MA, COFFMAN RL: Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136:2348-2357, 1986
2. MOSMANN T, COFFMAN R: Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 7:145-173, 1989
3. MOSMANN T, SAD S: The expanding universe of T-cell subsets: Th1, Th2, and more. Immunol Today 17:138-146, 1996
4. LOCKSLEY R, HEINZEL F, HOLADAY B, MUTHA S, REINER S, SADICK M: Induction of Th1 and Th2 CD4 subsets during murine L. major infection. Res Immunol 142:28-32, 1991
5. ROMAGNANI S: Lymphokine production by human T cells in disease states. Annu Rev Immunol 12:227-257, 1994
6. + T cell subset with an unrestricted cytokine profile. J Immunol 143:518-525, 1989
7. + T cell responses. Annu Rev Immunol 15:297-322, 1997
8. AUSTRUP F, VESTWEBER D, BORGES E, LOHNING M, BRAUER R, HERZ U, RENZ H, HALLMANN R, SCHEFFOLD A, RADBRUCH A, HAMANN A : P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflammed tissues. Nature 385:81-83, 1997
9. SALLUSTO F, MACKAY C, LANZAVECCHIA A: Selective expression of the eotaxin receptor CCCR3 by human T helper 2 cells. Science 277:2005-2007, 1997
10. + T cells. J Immunol 158:1055-1094, 1997
11. + T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. Proc Natl Acad Sci USA 90:10188-10192, 1993
12. SWAJN SL, WEINBERG AD, ENGLISH M, HUSTON G: IL-4 directs the development of Th2-like helper effectors. J Immunol 145:3796-3806, 1990
13. + T cells from T cell receptor transgenic mice. J Exp Med 176:1091-1098, 1992
14. KOPF M, LE GROS G, BACHMANN M, LAMERS MC, BLUETHMANN H, KOHLER G: Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362:245-248, 1993
15. MATTNER F, MAGRAM J, FERRANTE J, LAUNOIS P, DI PADOVA K, BEHIN R, GATELY M, LOUIS J, ALBER G: Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur J Immunol 26:1553-1559, 1996
16. MAGRAM J, CONNAUGHTON SE, WARRIER RR, CARVAJAL DM, WU C-Y, FERRANTE J, STEWART C, SAMIENTO U, FAHERTY DA, GATELY MK: IL-12-deficient mice are defective in IFN-gamma production and type 1 cytokine responses. Immunity 4:471-481, 1996
17. + T cells: A new family of T cells. Immunol Today 17:71-76, 1996
18. PORCELLI S: The CD1 family: A third lineage of antigen-presenting molecules. Adv Immunol 59:1-98, 1995
19. + T cell development and early IL-4 production in CD1-deficient mice. Immunity 6:459-467, 1997
20. BECKMAN E, PORCELLI S, MORITA C, BEHAR S, FURLONG S, BRENNER M: Recognition of a lipid antigen by CD1-restricted αβ+ Tcells. Nature 372:691-694, 1994
21. BLEICHER P, BALK S, HAGEN S, BLUMBERG R, FLOTTE T, TERHORST C: Expression of murine CD1 on gastrointestinal epithelium. Science 250:679-682, 1990
22. + CD8 single-positive thymocyte subpopulation that expresses a highly skewed T cell antigen receptor beta family. Proc Natl Acad Sci USA 89:6506-6510, 1992
23. + T lymphocytes. Sci0ence 268:863-865, 1995
24. + T cells that promptly produce interleukin 4. Proc Natl Acad Sci USA 92:11931-11934, 1995
25. +-like thymocytes in the NOD mouse. Eur J Immunol 26:2989-2998, 1996
26. + NK T cells associated with disease development in autoimmune-prone mice. J Immunol 156:4035-4040, 1996
27. SUMIDA T, SAKAMOTO A, MURATA H, MAKINO Y, TAKAHASHI H, YOSHIDA S, NISHIOKA K, IWAMOTO I, TANIGUCHI M: Selective reduction of T cells bearing invariant Vα24JαQ antigen receptor in patients with systemic sclerosis. J Exp Med 182:1163-1168, 1995
28. MENDIRATTA S, MARTIN W, HONG S, BOESTEANU A, JOYCE S, VAN KAER L: CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 6:469-477, 1997
29. + T cells in a Th2 response and in immunoglobulin E production. Science 270:1845-1847, 1995
30. + T cells. J Exp Med 185:461-469, 1997
31. PLAUT M, PIERCE J, WATSON C, HANLEY H, NORDAN R, PAUL W: Mast cell lines produce lymphokines in response to cross-linkage of FceRI or to calcium ionophores. Nature 339:64-67, 1989
32. SEDER R, PLAUT M, BARBIERI S, URBAN J, PAUL W: Mouse splenic and bone marrow cell populations that express high-affinity Fc epsilon receptors and produce interleukin 4 are highly enriched in basophils. Proc Natl Acad Sci USA 88:2835-2839, 1991
33. + T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice. Immunity 6:541-549, 1997
34. + T cells are not essential for T helper cell 2 immune responses. J Exp Med 184:1295-1304, 1996
35. TRINCHIERI G: Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev-Immunol 13:251-276, 1995
36. KAPLAN MH, SCHINDLER U, SMILEY ST, GRUSBY MJ: Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4:313-319, 1996
37. JACOBSON NG, SZABO SJ, WEBER-NORDT RM, ZHONE Z, SCHREIBER RD, DARNELL JE, MURPHY KM: Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4. J Exp Med 181:1755-1762, 1995
38. THIERFELDER WE, VAN DEURSEN JM, YAMATOMO K, TRIPP RA, SARAWAR SR, CARSON RR, SANGSTER MY, VIGNALI DAA, DEHERTY PC, GROSVELD GC, IHLE JN: Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382:171-174, 1996
39. ZHENG W-P, FLAVELL R: The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89:587-596, 1997
40. LOHOFF M, FERRICK D, MITTRUCKER H-W, DUNCAN G, BISCHOF S, ROLLINGHOFF M, MAK T: Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo. Immunity 6:681-689, 1997
41. TAKI S, SATO T, OGASAWARA K, FUKUDA T, SATO M, HIDA S, SUZUKI G, MITSUYAMA M, SHIN E-H, KOJIMA S, TANIGUCHI T, ASANO Y: Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity 6:673-679, 1997
42. REINER S, LOCKSLEY R: The regulation of immunity to Leishmania major. Annu Rev Immunol 13:151-177, 1995
43. MCINTYRE K, SHUSTER D, GILLOOLY K, WARRIER R, CONNAUGHTON S, HALL L, ARP L, GATELY M, MAGRAM J: Reduced incidence and severity of collagen-induced arthritis in interleukin-12-deficient mice. Eur J Immunol 26:2933-2938, 1996
44. STEINMAN L: Some misconceptions about understanding autoimmunity through experiments with knockouts. J Exp Med 185:2039-2041, 1997
45. FREI K, EUGSTER H, POPST M, CONSTANTINESCU C, LAVI E, FON-TANA A: Tumor necrosis factor and lymphotoxin-α are not required for induction of acute experimental autoimmune encephalomyelitis. J Exp Med 185:2177-2182, 1997
46. FERBER IA, BROCKE S, TAYLOR-EDWARDS C, RIDGWAY W, DINISCO C, STEINMAN L, DALTON D, FATHMAN CG: Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J Immunol 156:5-7, 1996
47. KRAKOWSKI M, OWENS T: Interferon-gamma confers resistance to experimental allergic encephalomyelitis. Eur J Immunol 26:1641-1646, 1996
48. GOLD D, SCHRODER K, POWELL H, KELLY C: Nitric oxide and the immunomodulation of experimental allergic encephalomyelitis. Eur J Immunol 27:2863-2869, 1997
49. PHAM K, SMOYER W, ARCHER D, GABBAI F, KELLY C: Oral feeding of renal tubular antigen abrogates interstitial nephritis and renal failure in Brown Norway rats. Kidney Int 52:725-732, 1997
50. WEINER H, FRIEDMAN A, MILLER A, KHOURY S, AL-SAGGAGH A, SANTOS L, SAYEGH M, NUSSENBLATT R, TRENTHAM D, HAFLER D: Oral tolerance: Immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol 12:809-837, 1994
51. + suppressor T cells which are antigen specific and inhibit the expression of disease. J Immunol 136:903-907, 1986
52. FORSTHUBER T, YIP H, LEHMANN P: Induction of Th1 and Th2 immunity in neonatal mice. Science 271:1728-1730, 1996
53. CHEN Y, KUCHROO V, INOBE J-I, HAFLER D, WEINER H: Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis. Science 265:1237-1240, 1994
54. MEYERS CM, KELLY CJ: Immunoregulation and TGF-β1. Suppression of a nephritogenic murine T cell clone. Kidney Int 46:1295-1301, 1994
55. MEYERS CM, KELLY CJ: Inhibition of murine nephritogenic effector T cells by a clone-specific suppressor factor. J Clin Invest 94:2093-2104, 1994
56. BAILEY N, FRISHBERG Y, KELLY C: Loss of high affinity TGF-β1 binding to a nephritogenic T cell results in absence of growth inhibition by TGF-β1 and augmented nephritogenicity. J Immunol 156:3009-3016, 1996
57. GENAIN C, ABEL K, BELMAR N, VILLINGER F, ROSENBERG D, LININGTON C, RAINE C, HAUSER S: Late complications of immune deviation therapy in a nonhuman primate. Science 274:2054-2057, 1996
58. LAFAILLE J, VAN DE KEERE F, Hsu A, BARON J, HAAS W, RAINE C, TONEGAWA S: Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. J Exp Med 186:307-312, 1997
59. PAKALA S, KURRER M, KATZ J: T helper 2 (Th2) cells induce acute pancreatitis and diabetes in immune-compromised nonobese dia-betic (NOD) mice. J Exp Med 186:299-306, 1997
60. HUANG X, TIPPING P, LI S, HOLDSWORTH S: Th1 responsiveness to nephritogenic antigens determines susceptibility to crescentic glomerulonephritis in mice. Kidney Int 51:94-103, 1997
61. PENNY M, BOYD R, HALL B: Role of T cells in the mediation of Heymann nephritis, ii. Identification of Th1 and cytotoxic cells in glomeruli. Kidney Int 51:1059-1068, 1997
62. TIPPING P, KITCHING A, HUANG X, MUTCH D, HOLDSWORTH S: Immune modulation with interleukin-4 and interleukin-10 prevents crescent formation and glomerular injury in experimental glomerulonephritis. Eur J Immunol 27:530-537, 1997
63. KITCHING A, TIPPING P, HUANG Z, MUTCH D, HOLDSWORTH S: Interleukin-4 and interleukin-10 attenuate established crescentic glomerulonephritis in mice. Kidney Int 52:52-59, 1997
64. CHADBAN S, TESCH G, LAN H, ATKINS R, NIKOLIC-PATERSON D: Effect of interleukin-10 on crescentic glomerulonephritis in rats. Kidney Int 51:1809-1817, 1997
65. HUANG X, HOLDSWORTH S, TIPPING P: Th2 responses induce humorally mediated injury in experimental anti-glomerular basement membrane glomerulonephritis. J Am Soc Nephrol 8:1101-1108, 1997
66. HIRSCH F, COUDERC J, SAPIN C, FOURNIE G, DRUET P: Polyclonal effects of HgCl2 in the rat: Its possible role in an experimental autoimmune disease. Eur J Immunol 12:620-625, 1982
67. PRIGENT P, SAOUDI A, PANNETIER C, GRABER P, BONNEFOY J-Y, DRUET P, HIRSCH F: Mercuric chloride, a chemical responsible for T helper cell mediated autoimmunity in Brown Norway rats, directly triggers T cells to produce interleukin-4. J Clin Invest 96:1484-1489, 1995
68. ERB K, RUGER B, VON BREVERN M, RYFFEL B, SCHIMPL A, RIVETT K: Constitutive expression of interleukin 4 in vivo causes autoimmune-type disorders in mice. J Exp Med 185:329-339, 1997
69. SANTIAGO M-L, FOSSATI L, JACOUET C, MULLER W, IZUI S, REININGER L: Interleukin-4 protects against a genetically linked lupus-like autoimmune syndrome. J Exp Med 185:65-70, 1997
70. ALLISON J: CD28-B7 interactions in T cell activation. Curr Opin Immunol 6:414-419, 1994
71. JUNE C, BLUESTONE J, NADLER L, THOMPSON C: The B7 and CD28 receptor families. Immunol Today 15:321-331, 1994
72. WALUNAS T, LENSCHOW D, BARKER C, LINSLEY P, FREEMAN G, GREEN J, THOMPSON C, BLUESTONE J: CTLA-4 can function as a negative regulator of T cell activation. Immunity 1:405-413, 1994
73. KRUMMEL M, ALLISON J: CD28 and CTLA-4 deliver opposing signals which regulate the response of T cells to stimulation. J Exp Med 182:459-465, 1995
74. KRUMMEL M, ALLISON J: CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J Exp Med 183:2533-2540, 1996
75. PERRIN P, MALDONADO J, DAVIS T, JUNE C, RACKE M: CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis. J Immunol 157:1333-1336, 1996
76. LEACH D, KRUMMEL M, ALLISON J: Enhancement of antitumor immunity by CTLA-4 blockade. Science 271:1734-1736, 1996
77. KARANDIKAR N, VANDERLUGT C, WALUNAS T, MILLER S, BLUESTONE J: CTLA-4: A negative regulator of autoimmune disease. J Exp Med 184:783-788, 1996
78. TIVOL E, BORRIELLO F, SCHWEITZER A, LYNCH W, BLUESTONE J, SHARPE A: Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3:541-547, 1995
79. WATERHOUSE P, PENNINGER J, TIMMS E, WAKEHAM A, SHANINIAN A, LEE K, THOMPSON C, GRIESSER H, MAK T: Lymphoproliterative disorders with early lethality in mice deficient in CTLA-4. Science 270:985-988, 1995
80. PEREZ V, PARUS L, BIUCKIANS A, ZHENG X, STROM T, ABBAS A: Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 6:411-417, 1997
81. REISER H, STADECKER M: Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune disease. N Engl J Med 335:1369-1377, 1996
82. FINCK B, LINSLEY P, WOFSY D: Treatment of murine lupus with CTLA4Ig. Science 265:1225-1227, 1994
83. NAKAJIMA A, AZUMA M, KODERA S: Preferential dependence of autoantibody production in murine lupus on CD86 costimulatory molecule. Eur J Immunol 25:3060-3069, 1995
84. LENSCHOW D, HO S, SATTAR H, RHEE L, GRAY G, NABAVI N, HEROLD K, BLUESTONE J: Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J Exp Med 181:1145-1155, 1995
85. LENSCHOW D, HEROLD K, RHEE L, PATEL B, KOONS A, QIN H-Y, FUCHS E, SINGH B, THOMPSON C, BLUESTONE J: CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes Immunity 5:285-293, 1996
86. MILLER SD, VANDERLUGT CL, LENSCHOW DJ, POPE JG, KARANDIKAR NJ, DAL CANTO MC, BLUESTONE JA: Blockage of CD28/B7-1 interaction prevents epitope spreading and clinical relapse. Immunity 3:739-745, 1995
87. KUCHROO VK, DAS MP, BROWN JA, RANGER AM, ZAMVIL SS, SOBEL RA, WEINER HL, NABAVI N, GLIMCHER LH: B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy. Cell 80:707-718, 1995
88. KNOERZER D, KARR R, SCHWARTZ B, MENGLE-GAW L: Collagen-induced arthritis in the BB rat: Prevention of disease by treatment with CTLA-4-Ig. J Clin Invest 96:987-993, 1995
89. DURIE FH, FAVA RA, FOY TM, ARUFFO A, LEDBETTER JA, NOELLE RJ: Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science 261:1328-1330, 1993
90. MOHAN C, SHI Y, LAMAN J, DATTA S: Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J Immunol 154:1470-1480, 1994
91. BIANCONE L, ANDRES G, AHN H, DEMARTINO C, STAMENKOVIC I: Inhibition of the CD40-CD40 ligand pathway prevents murine membraneous glomerulonephritis. Kidney Int 48:458-468, 1995
92. GRIGGS N, AGERSBORG S, NOELLE R, LEDBETTER J, LINSLEY P, TUNG KSK: The relative contribution of CD28 and gp39 costimulatory pathways in the clonal expansion and pathogenic acquisition of self-reactive T cells. J Exp Med 183:801-810, 1996
93. STUBER E, STROBER W, NEURATH M: Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J Exp Med 183:693-698, 1996
94. PENG S, MCNIFF J, MADAIO M, MA J, OWEN M, FLAVELL R, HAYDAY A, CRAFT J: Alpha beta T cell regulation and CD40 ligand dependence in murine systemic autoimmunity. J Immunol 158:2464-2470, 1997
95. GREWAL I, FOELLMER H, GREWAL K, XU J, HARDARDOTTIR F, BARON J, JANEWAY C, FLAVELL R: Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science 273:1864-1867, 1996
96. RANHEIM E, KIPPS T: Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal J Exp Med 177:925-935, 1993
97. DAVIS M, BJORKMAN P: T cell antigen receptor genes and T cell recognition. Nature 334:395-402, 1988
98. ACHA-ORBEA H, MITCHELL D, TIMMERMANN L, WRAITH D, TAUSCH G, WALDOR M, ZAMVIL S, MCDEVITT H, STEINMAN L: Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell 54:263-273, 1988
99. GOLD D, VAINIENE M, CELNIK B, WILEY S, GIBBS C, HASHIM G, VANDENBARK A, OFFNER H: Characterization of the immune response to a secondary encephalitogenic epitope of basic protein in Lewis rats. II. Biased T cell receptor V beta expression predominates in spinal cord infiltrating T cells. J Immunol 148:1712-1717, 1992
100. GOLD D, OFFNER H, SUN D, WILEY S, VANDENBARK A, WILSON D: Analysis of T cell receptor β chains in Lewis rats with experimental allergic encephalomyelitis: Conserved complementarity determining region 3. J Exp Med 174:1467-1476, 1991
101. BURNS F, LI X, SHEN N, OFFNER H, CHOU Y, VANDENBARK A, HEBER-KATZ E: Both rat and mouse T cell receptors specific for the encephalitogenic determinant of myelin basic protein use similar Va and Vβ chain genes even though the major histocompatibility complex and encephalitogenic determinants being recognized are different. J Exp Med 169:27-39, 1989
102. URBAN J, KUMAR V, KONO D, GOMEZ C, HORVATH S, CLAYTON J, ALDO D, SERCARZ E, HOOD L: Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell 43:577-592, 1988
103. VANDENBARK A, HASHIM G, OFFNER H: Immunization with a synthetic T cell receptor V region peptide protects against EAE. Nature 341:541-544, 1989
104. HOWELL M, WINTERS S, OLEE T, POWELL H, CARLO D, BROSTOFF S: Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science 246:668-669, 1989
105. OKSENBERG J, PANZARA M, BEGOVICH A, MITCHELL D, ERLICH H, MURRAY R, SHIMONKEVITZ R, SHERRITT M, ROTHBARD J, BERNARD C, STEINMAN L: Selection for T cell receptor Vβ-Dβ-Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature 362:68-70, 1993
106. GOLD D: TCR V gene usage in autoimmunity. Current Opin Immunol 6:907-912, 1994
107. SHE J-X: Susceptibility to Type I diabetes: HLA-DQ and DR revisited. Immunol Today 17:323-329, 1996
108. NEPOM G: A unified hypothesis for the complex genetics of HLA associations with IDDM. Diabetes 39:1153-1157, 1990
109. MOUDGIL K, SEKIGUCHI D, KIM S, SERCARZ E: Immunodominance is independent of structural constraints. Each region within hen egg white lysozyme is potentially available upon processing of native antigen. J Immunol 159:2574-2579, 1997
110. MACMICKING J, XIE Q-W, NATHAN C: Nitric oxide and macrophage function. Annu Rev Immunol 15:323-350, 1997
111. MILLS CD: Molecular basis of "suppressor" macrophages. Arginine metabolism via the nitric oxide synthetase pathway. J Immunol 146:2719-2723, 1991
112. GABBAI F, BOGGIANO C, PETER T, KHANG S, ARCHER C, GOLD D, KELLY C: Inhibition of inducible nitric oxide synthase intensifies injury and functional deterioration in autoimmune interstitial nephritis. J Immunol 159:6266-6275, 1997
113. BARON J, MADRI J, RUDDLE N, HASHIM G, JANEWAY C: Surface expression of alpha-4 integrin by CD4 T cells is required for their entry into brain parenchyme. J Exp Med 177:57-68, 1993
114. BARON J, REICH E, VISINTIN I, JANEWAY C: The pathogenesis of adoptive murine autoimmune diabetes requires an interaction between alpha 4-integrins and vascular cell adhesion molecule-1. J Clin Invest 93:1700-1708, 1994
115. TANG W, QI M, WARREN J: Monocyte chemoattractant protein 1 mediates glomerular macrophage infiltration in anti-GBM Ab GN. Kidney Int 50:665-671, 1996
116. TANG W, YIN S, WITTWER A, QI M: Chemokine gene expression in anti-glomerular basement membrane antibody glomerulonephritis. Am J Physiol 269:F323-F330, 1995
117. STAHL R, THAISS F, DISSER M, HELMCHEN U, HORA K, SCHLONDORFF D: Increased expression of monocyte chemoattractant protein-1 in anti-thymocyte antibody-induced glomerulonephritis. Kidney Int 44:1036-1047, 1993
118. LLOYD C, MINTO A, DORF M, PROUDFOOT A, WELLS T, SALANT D, GUTIERREZ-RAMOS J-C: RANTES and monocyte chemoattractant protein-1 play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis. J Exp Med 185:1371-1380, 1997
119. FENG L, XIA Y, YOSHIMURA T, WILSON C: Modulation of neutrophil influx in the rat with anti-macrophage inflammatory protein-2 antibody. J Clin Invest 95:1000-1017, 1995